Exhibition · Barcelona, Spain
Monoclonal Antibodies 2011
Health · Pharmaceuticals
Key numbers
- Editions on record
- 2first in 2011
About Monoclonal Antibodies
How successful are you in developing new monoclonal antibodies most effectively & bring them to the market? Come to Monoclonal Antibodies 2011 meeting to learn and network with the most important players on the mAbs market
Leading Biotech companies understand, how to grasp the commercial opportunities of mAbs market. All of them now have mAbs projects in their R&D portfolio. Introduction of newer monoclonal antibodies and targeting new therapeutic areas including cardiovascular, metabolic, neurological and infectious diseases will greatly expand the market.
Explore how to fully utilize the full potential of promising mAbs & succeed in a highly competitive market.
Evaluate unmet clinical needs and technological progress for the next generation of mAbs. Discuss key regulatory, IP and reimbursement challenges. Benchmark with your industry colleagues, how to develop and produce new generation products with improved efficacy, safety and pharmacokinetic profiles to keep one step ahead of the competition.
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2027 | 3–4 Feb 2027 Dates announced | Barcelona Barcelona, Spain | — | — |
| 2011 | 22–23 Sep 2011 | Barcelona Barcelona, Spain | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.